Effects of Caffeinated Beverages on Well-being

A Randomized, Decentralized, Crossover, Open-Label Trial to Assess Subjective and Physiological Responses to Consumption of Caffeinated Beverages in Healthy Adults With a Caffeine Routine

This study will evaluate post-beverage subjective caffeine responses and physiological responses to caffeinated beverages in generally healthy adults.

Study Overview

Detailed Description

This will evaluate post-beverage subjective caffeine responses using visual analog scale questionnaires, mood, quality of life, and physiological responses to caffeine beverages compared to participants' habitual caffeine beverage intake in generally healthy adults.

Study Type

Interventional

Enrollment (Estimated)

150

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: VP Product Innovation, Guayaki Sustainable Rainforest Products
  • Phone Number: 609-799-6067
  • Email: info@guayaki.com

Study Contact Backup

Study Locations

    • California
      • San Francisco, California, United States, 94109
        • Recruiting
        • Alethios, Inc.
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Males or females, ≥18 to ≤55 years of age
  2. BMI ≥18.5 and <29.9 kg/m2
  3. Generally good health
  4. Participant currently and consistently has a caffeine routine
  5. Participant is willing to substitute their current caffeine routine for the test beverage daily
  6. Participant has never consumed the test beverage or similar products
  7. Participant currently owns a wearable and is willing to use and connect the wearable device
  8. Willing to use personal smart phone, tablet, or personal computer with stable internet connection
  9. Willing and able to comply with all study procedures
  10. Willing to adhere to all study procedures, including lifestyle considerations and sign forms providing informed consent to participate in the study

Exclusion Criteria:

  1. History or presence, on the basis of the health history, of clinically important condition or disease states
  2. Is currently following, or planning to be on, a weight loss regimen
  3. Weight loss or gain >4.5 kg
  4. History of gastrointestinal surgery for weight reducing purposes or gastrointestinal (GI) conditions
  5. History of an eating disorder (e.g., anorexia nervosa or bulimia nervosa, binge eating) at the discretion of the Clinical Investigator.
  6. History of unconventional sleep patterns (e.g., night shift) or diagnosed sleep disorder
  7. Use of tobacco/nicotine products
  8. Use of hemp/marijuana products
  9. Unstable use of any prescription medication
  10. Use of any medications(s) or dietary supplement(s), containing caffeine, or interacting with caffeine
  11. Recent history of alcohol or substance abuse
  12. Exposed to any non-registered drug product
  13. Self-report of hypertension/high blood pressure without use of hypertensive medications
  14. Any known allergy or intolerance to any ingredients contained in the study product
  15. Any signs or symptoms of active infection of clinical relevance
  16. History or presence of cancer, except for non-melanoma skin cancer
  17. History of any major trauma or major surgical event
  18. Female who is pregnant, planning to be pregnant during the study period, lactating
  19. An employee, close relative of an employee, or participant who has a financial interest in Sponsor company or any other caffeine beverage company.
  20. Any condition the Investigator believes would interfere with the participant's ability to provide informed consent or comply with the study protocol
  21. A clinically significant medical condition that is affected by caffeine

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Test caffeinated beverage followed by participants' typical caffeinated beverage
Participants will consume the caffeinated beverage they typically consume.
Participants will consume a test beverage that contains caffeine.
Other: Participants' typical caffeinated beverage followed by test caffeinated beverage
Participants will consume the caffeinated beverage they typically consume.
Participants will consume a test beverage that contains caffeine.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Subjective caffeine visual analog scales
Time Frame: After 5 days of daily consumption
Participants will rate how they feel on a horizontal line. Lines will be flanked with perceived feelings. Scores range from 0-100, where a higher score indicates increase in that feeling.
After 5 days of daily consumption

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Subjective caffeine visual analog scales
Time Frame: Up to 5 hours after beverage consumption
Participants will rate how they feel on a horizontal line. Lines will be flanked with perceived feelings. Scores range from 0-100, where a higher score indicates increase in that feeling.
Up to 5 hours after beverage consumption
Subjective quality of life ratings
Time Frame: After 5 days of daily consumption
Participants will rate how they feel using a Likert scale from 0-5. Where higher score indicate higher frequency in that feeling.
After 5 days of daily consumption

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physiological responses - Heart rate
Time Frame: Up to 5 hours post-beverage consumption and after 5 days of daily beverage consumption
Data collected by wearables
Up to 5 hours post-beverage consumption and after 5 days of daily beverage consumption
Subjective beverage experience ratings
Time Frame: After 5 days of daily consumption
Participants will rate how they feel on a horizontal line. Lines will be flanked with perceived feelings. Scores range from 0-100, where a higher score indicates increase in that feeling.
After 5 days of daily consumption
Physiological response - Sleep
Time Frame: Up to 5 hours post-beverage consumption and after 5 days of daily beverage consumption
Data collected by wearables
Up to 5 hours post-beverage consumption and after 5 days of daily beverage consumption
Physiological responses - Activity
Time Frame: Up to 5 hours post-beverage consumption and after 5 days of daily beverage consumption
Data collected by wearables
Up to 5 hours post-beverage consumption and after 5 days of daily beverage consumption

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Kristin Nieman, PhD, Nlumn LLC

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 3, 2025

Primary Completion (Estimated)

April 1, 2026

Study Completion (Estimated)

April 1, 2026

Study Registration Dates

First Submitted

December 26, 2025

First Submitted That Met QC Criteria

January 13, 2026

First Posted (Actual)

January 22, 2026

Study Record Updates

Last Update Posted (Actual)

January 22, 2026

Last Update Submitted That Met QC Criteria

January 13, 2026

Last Verified

December 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • NL-2502

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Participants' typical caffeinated beverage

Subscribe